HTFL
Heartflow, Inc.
Key Financials
Gross Profit
$135.2M
↑ 43.1%
Operating Income
$-64066000
↓ 4.6%
Revenue
$176.0M
↑ 39.9%
EPS (Diluted)
$-3.17
↑ 82.4%
Net Income
$-116791000
↓ 21.1%
Shareholders' Equity
$300.6M
↑ 135.0%
Cash & Equivalents
$44.8M
↓ 12.8%
Total Liabilities
$58.8M
↓ 71.9%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 144 | 8/14/2026 | View on SEC |
| 144 | 8/14/2026 | View on SEC |
| 144 | 8/14/2026 | View on SEC |
| SCHEDULE 13G/A | 8/14/2026 | View on SEC |
| 10-Q | 8/13/2026 | View on SEC |
| SCHEDULE 13G/A | 8/13/2026 | View on SEC |
| 8-K | 8/13/2026 | View on SEC |
| 4 | 8/12/2026 | View on SEC |
| 4 | 8/10/2026 | View on SEC |
| 4 | 8/10/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | HTFL |
| Company Name | Heartflow, Inc. |
| CIK | 1464521 |
| Sector | Surgical & Medical Instruments & Apparatus |
| Industry | Non-accelerated filer Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 3841 |
| SIC Description | Surgical & Medical Instruments & Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 650-241-1221 |